Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial

NCT ID: NCT05579158

Last Updated: 2024-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

337 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In non-alcoholic fatty liver disease (NAFLD), it is established that calorie restriction is the most essential dietary modification. The time-restricted diet is successful lowering total calorie consumption and insulin resistance, and is anticipated to be beneficial for patients with NAFLD. Therefore, this study aims to conduct a prospective study to determine the effect of time-restricted diet via a mobile application on the amount of intrahepatic fat and 10-year cardiovascular disease risk in patients with NAFLD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Alcoholic Fatty Liver Disease Time Restricted Feeding Mobile Technology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobile application-supported both calorie restriction and time-restricted eating (mCR/TRE)

This arm receives wearable device and mobile application-supported nutritional counseling for four months. The nutritional counseling consists of both calorie restriction (500kcal below estimated energy requirement) and time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day).

Group Type EXPERIMENTAL

Mobile application and wearable device

Intervention Type BEHAVIORAL

Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity

Time-restricted eating

Intervention Type BEHAVIORAL

Time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day)

Mobile application-supported calorie restriction (mCR)

This arm receives wearable device and mobile application-supported nutritional counseling for four months. The nutritional counseling consists of only calorie restriction (500kcal below estimated energy requirement).

Group Type ACTIVE_COMPARATOR

Mobile application and wearable device

Intervention Type BEHAVIORAL

Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity

Calorie restriction (CR)

Standard of care. This arm receives a brief counseling of calorie restriction.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile application and wearable device

Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity

Intervention Type BEHAVIORAL

Time-restricted eating

Time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged ≥ 19 years who are willing and able to complete all procedures
* Hepatic steatosis by imaging (ultrasound, computed tomography, magnetic resonance imaging, and controlled attenuation parameter (≥260 dB/m))

Exclusion Criteria

* Body mass index (BMI) \<23
* Other causes of chronic liver disease (HBV, HCV), autoimmune diseases or chronic cholestatic liver disease
* Medications which cause liver disease or secondary hepatic steatosis (Tamoxifen, systemic corticosteroids, methotrexate, tetracycline, estrogens, valproic acid, and statin (registration is possible if statin is delivered in a consistent dosage within 12 weeks)
* Significant alcohol intake (\>210g/week for men, \>140g/week for women)
* Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure \> 200/120 mmHg)
* Psychiatric illnesses which limit ability to exercise safely
* Diagnosed with diabetes on medication or insulin
* Participation in a weight-loss program within 12 weeks
* MRI contraindications
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Health, Korea

OTHER_GOV

Sponsor Role collaborator

Hanyang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dae Won Jun

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dae Won Jun, M.D., Ph.D.

Role: STUDY_CHAIR

Hanyang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hanyang University Seoul Hospital

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

References

Explore related publications, articles, or registry entries linked to this study.

Oh JH, Yoon EL, Park H, Lee S, Jo AJ, Cho S, Kwon E, Nah EH, Lee JH, Park JH, Ahn SB, Jun DW. Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2025 Jun 19:S0168-8278(25)02272-X. doi: 10.1016/j.jhep.2025.06.005. Online ahead of print.

Reference Type DERIVED
PMID: 40543603 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HanyangU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Time Restricted Eating in Obese Adults
NCT05660291 ACTIVE_NOT_RECRUITING NA